Literature DB >> 16160185

Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.

Cheryl Pikora1, Christine Wittish, Ronald C Desrosiers.   

Abstract

Using PCR mutagenesis to disrupt the NXT/S N-linked glycosylation motif of the Env protein, we created 27 mutants lacking 1 to 5 of 14 N-linked glycosylation sites within regions of gp120 lying outside of variable loops 1 to 4 within simian immunodeficiency virus strain 239 (SIV239). Of 18 mutants missing N-linked glycosylation sites predicted to lie within 10 A of CD4 contact sites, the infectivity of 12 was sufficient to measure sensitivity to neutralization by soluble CD4 (sCD4), pooled immune sera from SIV239-infected rhesus macaques, and monoclonal antibodies known to neutralize certain derivatives of SIV239. Three of these 12 mutants (g3, lacking the 3rd glycan at position 79; g11, lacking the 11th glycan at position 212; and g3,11, lacking both the 3rd and 11th glycans) were approximately five times more sensitive to neutralization by sCD4 than wild-type (WT) SIV239. However, these same mutants were no more sensitive to neutralization than WT by pooled immune sera. The other 9 of 12 replication-competent mutants in this group were no more sensitive to neutralization than the WT by any of the neutralizing reagents. Six of the nine mutants that did not replicate appreciably had three or more glycosylation sites eliminated; the other three replication-deficient strains involved mutation of site 15. Our results suggest that elimination of glycan attachment sites 3 and 11 enhanced the exposure of contact residues for CD4. Thus, glycans at positions 3 and 11 of SIV239 gp120 may be particularly important for shielding the CD4-binding site from antibody recognition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160185      PMCID: PMC1211561          DOI: 10.1128/JVI.79.19.12575-12583.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  HIV glycosylation: what does it portend?

Authors:  G Myers; R Lenroot
Journal:  AIDS Res Hum Retroviruses       Date:  1992-08       Impact factor: 2.205

2.  Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1.

Authors:  W R Lee; W J Syu; B Du; M Matsuda; S Tan; A Wolf; M Essex; T H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

3.  Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants.

Authors:  P Kolchinsky; E Kiprilov; J Sodroski
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins.

Authors:  J A Hoxie
Journal:  AIDS Res Hum Retroviruses       Date:  1991-06       Impact factor: 2.205

5.  Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.

Authors:  K A Kent; L Gritz; G Stallard; M P Cranage; C Collignon; C Thiriart; T Corcoran; P Silvera; E J Stott
Journal:  AIDS       Date:  1991-07       Impact factor: 4.177

Review 6.  Glucosidase inhibitors for treatment of HIV-1 infection.

Authors:  L Ratner
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

7.  Complex determinants of macrophage tropism in env of simian immunodeficiency virus.

Authors:  K Mori; D J Ringler; T Kodama; R C Desrosiers
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides.

Authors:  H B Bernstein; S P Tucker; E Hunter; J S Schutzbach; R W Compans
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.

Authors:  H G Morrison; F Kirchhoff; R C Desrosiers
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

10.  Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function.

Authors:  D A Dedera; R L Gu; L Ratner
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

View more
  20 in total

1.  The highly conserved glycan at asparagine 260 of HIV-1 gp120 is indispensable for viral entry.

Authors:  Katrien O François; Jan Balzarini
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

2.  Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization.

Authors:  James M Binley; Yih-En Andrew Ban; Emma T Crooks; Dirk Eggink; Keiko Osawa; William R Schief; Rogier W Sanders
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.

Authors:  Samantha Townsley; Yun Li; Yury Kozyrev; Brad Cleveland; Shiu-Lok Hu
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

4.  Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.

Authors:  Po-Jen Yen; Megan E Mefford; James A Hoxie; Kenneth C Williams; Ronald C Desrosiers; Dana Gabuzda
Journal:  Virology       Date:  2014-05-08       Impact factor: 3.616

5.  A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.

Authors:  Michael D Alpert; Lisa N Heyer; David E J Williams; Jackson D Harvey; Thomas Greenough; Maria Allhorn; David T Evans
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

6.  CD4+ T cells support production of simian immunodeficiency virus Env antibodies that enforce CD4-dependent entry and shape tropism in vivo.

Authors:  Nicholas Francella; Sarah E Gwyn; Yanjie Yi; Bing Li; Peng Xiao; Sarah T C Elliott; Alexandra M Ortiz; James A Hoxie; Mirko Paiardini; Guido Silvestri; Cynthia A Derdeyn; Ronald G Collman
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

7.  Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge.

Authors:  Michael D Alpert; Andrew R Rahmberg; William Neidermyer; Sharon K Ng; Angela Carville; Jeremy V Camp; Robert L Wilson; Michael Piatak; Keith G Mansfield; Wenjun Li; Christopher J Miller; Jeffrey D Lifson; Pamela A Kozlowski; David T Evans
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

8.  Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.

Authors:  Li-Hua Ping; Sarah B Joseph; Jeffrey A Anderson; Melissa-Rose Abrahams; Jesus F Salazar-Gonzalez; Laura P Kincer; Florette K Treurnicht; Leslie Arney; Suany Ojeda; Ming Zhang; Jessica Keys; E Lake Potter; Haitao Chu; Penny Moore; Maria G Salazar; Shilpa Iyer; Cassandra Jabara; Jennifer Kirchherr; Clement Mapanje; Nobubelo Ngandu; Cathal Seoighe; Irving Hoffman; Feng Gao; Yuyang Tang; Celia Labranche; Benhur Lee; Andrew Saville; Marion Vermeulen; Susan Fiscus; Lynn Morris; Salim Abdool Karim; Barton F Haynes; George M Shaw; Bette T Korber; Beatrice H Hahn; Myron S Cohen; David Montefiori; Carolyn Williamson; Ronald Swanstrom
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses.

Authors:  Yun Li; Bradley Cleveland; Igor Klots; Bruce Travis; Barbra A Richardson; David Anderson; David Montefiori; Patricia Polacino; Shiu-Lok Hu
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization.

Authors:  Emma T Crooks; Pengfei Jiang; Michael Franti; Sharon Wong; Michael B Zwick; James A Hoxie; James E Robinson; Penny L Moore; James M Binley
Journal:  Virology       Date:  2008-06-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.